Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03915379
Title A Study of JNJ-67571244 in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | DEU

Facility Status City State Zip Country Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
NYU Hematology Associates New York New York 10016 United States Details
Levine Cancer Institute, Carolinas HealthCare System Charlotte North Carolina 28204 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98109 United States Details
Universitaetsklinikum Leipzig Leipzig 04103 Germany Details
Klinikum der Universitaet Muenchen München 81377 Germany Details
Universitätsklinikum Münster; Med. Klinik A - Germany Münster 48149 Germany Details
Hosp. Clinic I Provincial de Barcelona Barcelona 08036 Spain Details
Hosp. Univ. Vall D Hebron Barcelona 8035 Spain Details
Hosp. Univ. Fund. Jimenez Diaz Madrid 28040 Spain Details
Clinica Univ. de Navarra Pamplona 31008 Spain Details
Hosp. Virgen Del Rocio Sevilla 41013 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field